(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Biophotonics - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global biophotonics market was valued at US$66.7 billion in 2025 and is projected to reach US$130.6 billion by 2032, expanding at a compound annual growth rate (CAGR) of 10.1% during the forecast period. The market's strong outlook reflects continued advances in optical imaging, diagnostics, biosensing, medical therapeutics and life sciences research.
Global Biophotonics Market Trends and Growth Drivers
Biophotonics technologies are transforming the analysis, imaging and manipulation of biological materials across clinical, pharmaceutical, research, environmental and agricultural applications. Innovations in super-resolution fluorescence microscopy, optical coherence tomography (OCT), flow cytometry, endoscopy and fluorescence in situ hybridization are improving resolution, sensitivity, specificity and real-time analytical capabilities.
Clinical adoption remains a major contributor to global biophotonics market growth. Biophotonic imaging and diagnostic systems support cancer detection, ophthalmology, pathology, minimally invasive procedures and treatment monitoring. OCT continues to gain importance in ophthalmic diagnostics, while laser-based systems are advancing surgical and therapeutic procedures. Pharmaceutical and biotechnology companies also use multiparameter fluorescence detection and high-throughput screening to accelerate drug discovery and development.
Advances in imaging and sensing technologies are enabling deeper tissue penetration, higher-resolution visualization and more accurate biological analysis. Artificial intelligence and machine learning are further improving image processing, data interpretation and workflow automation. These capabilities are expanding the use of biophotonics in precision medicine, where accurate diagnostics and treatment monitoring support more individualized care strategies.
Demand for minimally invasive and non-invasive medical procedures is strengthening adoption across hospitals and clinics. Regulatory approvals, device standardization and collaboration among academic institutions, research laboratories and industry participants are also supporting commercialization. Beyond healthcare, optical sensors are being adopted in environmental monitoring, agriculture, food quality and safety testing, creating additional opportunities for biophotonics technology providers.
Report Scope
The report provides an independent analysis of the global biophotonics market in terms of market value, with annual sales forecasts from 2025 through 2032. Coverage includes the following segments:
Type: Imaging systems, lasers, fiber optics and other types. Technology: In-vitro and in-vivo technologies. Usage: Tests and components, medical therapeutics, medical diagnostics and non-medical applications. Application: Surface imaging, inside imaging, see-through imaging, microscopy, biosensors, light therapy, optical coherence tomography and other applications. End Use: Hospitals and clinics, academic and research institutes, biotechnology and pharmaceutical companies, food-quality laboratories and other end users. Geographic Coverage: United States, Canada, Japan, China, Europe, Asia-Pacific and the Rest of World. European analysis includes France, Germany, Italy, the United Kingdom and other European markets.
Key Biophotonics Market Insights
The imaging systems segment is forecast to reach US$53.5 billion by 2032, growing at a CAGR of 11.6%. The lasers segment is projected to expand at a CAGR of 8.4% during the analysis period. The United States biophotonics market was valued at US$19.5 billion in 2025. China is forecast to grow at a CAGR of 9.5%, reaching US$22.7 billion by 2032. Japan, Canada, Germany and the broader Asia-Pacific region are expected to offer additional growth opportunities as healthcare infrastructure, research investment and advanced diagnostic adoption increase.
Strategic Value of the Report
Detailed analysis of the global biophotonics market across technologies, applications, end users and geographic regions. Competitive intelligence covering leading companies and their presence in major markets. Assessment of the trends, growth drivers, restraints and emerging opportunities shaping the industry through 2032. Actionable insights designed to support strategic planning, market entry, investment evaluation and revenue development. Company profiles and market intelligence covering established participants and influential technology providers. Complimentary report updates for one year, providing access to relevant market developments.
Key Questions Addressed
How will the global biophotonics market develop through 2032? Which technologies, applications and end-use segments are expected to achieve the strongest growth? What factors are driving or restraining market expansion? How will regional and segment-level competitive positions change during the forecast period? Which companies are influencing innovation and commercialization in the biophotonics industry?
Companies Featured
F. Hoffmann-La Roche AG GE Healthcare Horiba Ltd. IDEX Corporation IPG Photonics Corporation Koninklijke Philips NV The Procter & Gamble Company Qiagen, Inc.
Domain Expert Insights and Report Differentiators
Domain Expert Perspectives: The analysis incorporates insights from industry, enterprise and academic specialists to add strategic context beyond conventional published research. Early Market Signals: The report tracks developments emerging from expert discussions, company activity and market-relevant conversations before they are fully reflected in traditional secondary research. Validated Intelligence Base: Findings draw on conference sessions, keynote presentations, panel discussions, corporate disclosures, annual reports, institutional publications, industry commentary and other validated sources. Strategic Market Direction: The report connects market signals with commercial implications, identifying the developments most likely to influence investment, innovation and competitive strategy. Company Intelligence: Coverage extends beyond market-level forecasts to examine organizations participating in and shaping the global competitive environment. Relevant Market Share Analysis: Competitive structures are assessed at the geographic and segment levels where market share analysis provides meaningful strategic value.
The report equips executives, investors, product strategists, healthcare technology providers and research organizations with the market data and competitive intelligence needed to evaluate opportunities in the rapidly expanding global biophotonics market.
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment